Colgate-Palmolive (CL) Vice Chairman Sells $2,091,000.00 in Stock

Colgate-Palmolive (NYSE:CL) Vice Chairman Franck J. Moison sold 30,000 shares of the stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $69.70, for a total value of $2,091,000.00. Following the completion of the transaction, the insider now directly owns 211,048 shares of the company’s stock, valued at $14,710,045.60. The sale was disclosed in a filing with the SEC, which is available at this link.

Colgate-Palmolive (CL) traded up $0.11 during midday trading on Tuesday, reaching $70.30. The company had a trading volume of 3,373,435 shares, compared to its average volume of 4,439,941. The company has a market cap of $61,510.00, a price-to-earnings ratio of 30.83, a PEG ratio of 2.58 and a beta of 0.75. Colgate-Palmolive has a 1-year low of $67.19 and a 1-year high of $77.91. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.75. The firm had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $0.75 EPS. research analysts anticipate that Colgate-Palmolive will post 3.18 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s payout ratio is 70.18%.

A number of brokerages have recently issued reports on CL. Citigroup increased their target price on Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a report on Tuesday, January 30th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group restated a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a research report on Friday, January 26th. Zacks Investment Research upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research report on Tuesday, January 16th. Finally, Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a research report on Tuesday, December 19th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the stock. Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $77.71.

A number of institutional investors and hedge funds have recently made changes to their positions in CL. Renaissance Technologies LLC boosted its position in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after buying an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. boosted its position in Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock valued at $296,557,000 after buying an additional 2,884,100 shares during the last quarter. Harding Loevner LP boosted its position in Colgate-Palmolive by 92.0% in the 3rd quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock valued at $176,329,000 after buying an additional 2,272,675 shares during the last quarter. First Eagle Investment Management LLC boosted its position in Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after buying an additional 1,750,417 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares during the last quarter. Hedge funds and other institutional investors own 72.85% of the company’s stock.

WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2018/02/13/colgate-palmolive-cl-vice-chairman-sells-2091000-00-in-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply